1. Rosiglitazone attenuates paraquat-induced lung fibrosis in rats in a PPAR gamma-dependent manner
   Honglei Zhang et al, 2019, European Journal of Pharmacology CrossRef
2. Imaging Biomarkers in Animal Models of Drug-Induced Lung Injury: A Systematic Review
   Irma Mahmutovic Persson et al, 2020, Journal of Clinical Medicine CrossRef
3. Therapeutic molecular targets of SSc-ILD
   Yun Zhang et al, 2020, Journal of Scleroderma and Related Disorders CrossRef
4. Diabetic endothelial microangiopathy and pulmonary dysfunction
   Lanlan Zhang et al, 2023, Frontiers in Endocrinology CrossRef
5. Emerging roles of ferroptosis in pulmonary fibrosis: current perspectives, opportunities and challenges
   Yixiang Hu et al, 2024, Cell Death Discovery CrossRef
6. Diabetes mellitus and idiopathic pulmonary fibrosis: a Mendelian randomization study
   Quou Kang et al, 2024, BMC Pulmonary Medicine CrossRef
7. Glycolysis and beyond in glucose metabolism: exploring pulmonary fibrosis at the metabolic crossroads
   Yuejiao Wang et al, 2024, Frontiers in Endocrinology CrossRef
8. Diabetes Mellitus Contributes to Idiopathic Pulmonary Fibrosis: A Review From Clinical Appearance to Possible Pathogenesis
   Dongguang Wang et al, 2020, Frontiers in Public Health CrossRef